Purpose The objective of this study was to compare Scopus journals published in East Asian countries—China, Japan, South Korea, and Taiwan—in terms of their open access status and metrics and to explore the implications of those findings for South Korea.
Methods To conduct this study, we selected four East Asian countries: China, Japan, South Korea, and Taiwan. We used journal information provided by SCImago Journal Rank (SJR) and Scopus. The following parameters were analyzed for journals published in East Asian countries: open access status, subject categories, quartiles, number of published documents, h-index, publishers, and citation rate.
Results In all East Asian countries, numerous commercial publishers publish journals. One exception is Science Press, a Chinese government-sponsored publisher, which published the largest number of journals in the East Asian region. Japan had the highest median number of years covered by SJR. However, the proportion of Q1 journals in Japan was the lowest of the East Asian countries. South Korea had the highest proportion of Q1 journals in the country’s total journal production. Publishers in South Korea published more open access journals than any other East Asian country. Despite publishing a high proportion of prestigious journals, South Korea lagged behind China and Japan in the number of Scopus-indexed journals.
Conclusion The findings indicate that South Korea has made significant progress in locally producing influential journals over the years. However, more efforts to publish international journals are required for South Korea to increase the number of Scopus journals.
Citations
Citations to this article as recorded by
In-Depth Examination of Coverage Duration: Analyzing Years Covered and Skipped in Journal Indexing Eungi Kim Publications.2024; 12(2): 10. CrossRef
Demystifying multilingual LIS journals in Scopus: Languages, coverage, metrics, and implications Eungi Kim Journal of Librarianship and Information Science.2024;[Epub] CrossRef
Purpose This study aimed to compare the length limits specified in the author guidelines with the actual length of abstracts in 90 journals in the fields of pharmacology, oncology, and neurology. Specifically, the following parameters were examined: abstract formats among the three subject areas; the relationship between the length limit and the actual length of abstracts; and actual abstract length according to the number of subheadings, the length of structured abstract subheadings, the length of frequently used subheading sets, and clinical trial registration information.
Methods Thirty journals from each of three medical fields (pharmacology, oncology, and neurology) were selected from Elsevier’s Scimago Journal Rank. This included the journals indexed in PubMed from 2018 to 2019 that published the most articles. Article abstracts from these journals were used to create a dataset for this study. Descriptive, comparative, and correlational analyses of data for the three fields were conducted.
Results The number of subheadings and abstract length increased in parallel. The Results component was the longest, suggesting that authors tended to use longer text to report results than for other structural abstract components. Authors generally utilized the length limit to a full extent without exceeding it.
Conclusion The traditionally used 250-word length limit should be reconsidered for pharmacology, oncology, and neurology journals because it disregards the distinctive characteristics of abstracts and length differences between structured and unstructured abstracts. Various characteristics of abstract lengths presented in this study should be considered to establish more justifiable policies.
Citations
Citations to this article as recorded by
The use of subject headings varied in Embase and MEDLINE: An analysis of indexing across six subject areas Tove Faber Frandsen, Anne-Marie Fiala Carlsen, Mette Brandt Eriksen Journal of Information Science.2024; 50(4): 851. CrossRef